Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
ONPATTRO Inf Konz 10 mg/5ml Durchstf 5 ml
Drug
Onpattro, Konzentrat zur Herstellung einer Infusionslösung
Onpattro wird zur Behandlung der hereditären Transthyretin-Amyloidose (hATTR-Amyloidose) bei erwachsenen Patienten mit Polyneuropathie der Stadien 1 oder 2 angewendet
01.99.0. – various
HAM – Human medicine
LSPA – Parenteral solution
TGT – transplant product: gene therapy product
B – Dispensed on prescription by a physician or veterinarian (B)
Z – approved
9/23/2019
12/31/9999
Dosage strength
Onpattro 2 mg/ml, Konzentrat zur Herstellung einer Infusionslösung
Onpattro wird zur Behandlung der hereditären Transthyretin-Amyloidose (hATTR-Amyloidose) bei erwachsenen Patienten mit Polyneuropathie der Stadien 1 oder 2 angewendet
01
Z – approved
Package
7680673040010
No information made available
A/R – Authorised / referenced
1 vial(s)
IV – Intravenous use
001
Z – approved
Declaration
Component
2 mg patisiranum
patisiranum natricum
patisiranum natricum
DLin-MC3-DMA
1,2-dimyristoyl-sn-glycero-3-carboxaminopropylmacrogoli 2000 aether methylicus
1,2-distearoyl-sn-glycero-3-phosphocholinum
cholesterolum
dinatrii phosphas heptahydricus
kalii dihydrogenophosphas
natrii chloridum
aqua ad iniectabile
3.99 mg natrium
1,2-dimyristoyl-sn-glycero-3-carboxaminopropylmacrogoli 2000 aether methylicus
1,2-distearoyl-sn-glycero-3-phosphocholinum
cholesterolum
dinatrii phosphas heptahydricus
kalii dihydrogenophosphas
natrii chloridum
aqua ad iniectabile
3.99 mg natrium
Spezialitätenliste***
SL
-
-
8466.00
None
Yes
10%
No
Authorisation holder
7601001408906
Alnylam Switzerland GmbH
Grafenauweg 4
6300 Zug (ZG)
Grafenauweg 4
6300 Zug (ZG)
Date of revision of the text
7/4/2024
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.